National Board of Chiropractic Examiners (NBCE) Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the National Board of Chiropractic Examiners Test. Utilize interactive quizzes and comprehensive study guides for each subject. Gain confidence and ensure you're exam-ready!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


A single, nontender, firm breast mass with ill-defined margins is most characteristic of which disorder?

  1. Breast cyst

  2. Fibroadenoma

  3. Invasive ductal carcinoma

  4. Benign breast tissue

The correct answer is: Invasive ductal carcinoma

The presence of a single, nontender, firm breast mass with ill-defined margins is most characteristic of invasive ductal carcinoma. This type of breast cancer often presents as a palpable mass that may demonstrate irregular borders, indicating its potential aggressive nature and the ability to infiltrate surrounding tissues. Additionally, the firm consistency of the mass can be attributed to the presence of desmoplastic stromal reaction that often accompanies carcinomatous lesions. Invasive ductal carcinoma typically lacks tenderness and can vary in size, but its ill-defined margins distinguish it from benign conditions that usually present with well-defined borders. For example, breast cysts and fibroadenomas generally have more distinct margins and are often softer or mobile. Benign breast tissue does not characterize itself as a singular mass but rather presents as diffuse changes or nodularity in the breast. Recognizing the characteristics of breast masses is essential for appropriate differential diagnosis and management, as suspicious features like ill-defined margins raise concern for malignancy and necessitate further evaluation. It is crucial for healthcare providers to be aware of these distinctions, as early detection can significantly influence patient outcomes in breast cancer management.